Home Use Lancing Devices Market : Global Opportunity Analysis and Industry Forecast, 2024-2033
商品番号 : SMB-73844
| 出版社 | Allied Market Research |
| 出版年月 | 2024年10月 |
| ページ数 | 280 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,425 |
| 種別 | 英文調査報告書 |
Home Use Lancing Devices Market
The home use lancing devices market was valued at $359.5 million in 2023 and is projected to reach $537.8 million by 2033, growing at a CAGR of 4.1% from 2024 to 2033.
家庭用穿刺器具市場は2023年に3億5,950万ドルと評価され、2024年から2033年まで4.1%のCAGRで成長し、2033年までに5億3,780万ドルに達すると予測されています。
A home use lancing device is a hand-held blood sampling instrument that measures blood glucose levels. It is a minimally invasive device that makes a small incision on the skin to draw out blood. The design of the device is similar to a pen that houses a small, sterile needle or lancet to puncture the skin, along with a trigger mechanism to release it. The key benefits of a home use lancing device include its convenience, cost-effectiveness, adjustable depth, and ease of use.
家庭用穿刺器具は、血糖値を測定する手持ち式採血器具です。皮膚に小さな切開を加えて血液を抜き出す、低侵襲の器具です。このデバイスの設計は、皮膚を穿刺するための小さな滅菌針またはランセットと、それを解放するためのトリガー機構を内蔵したペンに似ています。家庭用穿刺器具の主な利点には、利便性、費用対効果、調整可能な深さ、使いやすさが含まれます。
Increase in the prevalence of diabetes has fueled the need for regular diagnosis, driving the growth of the home use lancing devices market. In addition, advancements in the design of the device have enhanced the user-friendliness and precision of blood extraction, thereby augmenting the market development. The transition of lancing devices into smart equipment is a prominent trend anticipated to dominate the market in coming years. The integration of the device with mobile applications and digital health platforms is projected to enhance decision-making and facilitate the provision of instant cure in case of emergencies.
However, the recurrent cost of purchasing disposable lancets deters several individuals from investing in the equipment, hampering the development of the home use lancing devices market. Furthermore, high saturation of the market reduces profit margin and restrains the market growth significantly. On the contrary, exponential growth in the number of individuals suffering from diabetes is anticipated to present lucrative opportunities for market expansion. According to the International Diabetes Federation, the cases of diabetes are projected to increase by 46% by 2045. Approximately 783 million individuals are expected to be living with diabetes in the future. This is poised to fuel the adoption of home use lancing devices, opening new avenues for market growth.
Segment Review
The home use lancing devices market is segmented into type, application, distribution channel, and region. On the basis of type, the market is divided into standard lancet, safety lancet, and others. Depending on application, it is classified into glucose testing, cholesterol testing, and others. As per distribution channel, it is bifurcated into online channel and offline channel. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of type, the safety lancet segment dominated the market in 2023.
Depending on application, the glucose testing segment held a high share of the market in 2023.
As per distribution channel, the online channel segment acquired a high stake in the market in 2023.
Region wise, North America was the highest revenue generator in 2023.
Competition Analysis
The leading players operating in the global home use lancing devices market include Medtronic Plc, Integra Lifesciences Corporation, Unilife Corporation, LifeScan, Novo Nordisk A/S, Owen Mumford Ltd., Ypsomed AG, F. Hoffmann-La Roche Ltd., Terumo Corporation, and ARKRAY Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Patient/epidemiology data at country, region, global level
- Regulatory Guidelines
- Additional company profiles with specific to client’s interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- SWOT Analysis
Home Use Lancing Devices Market , by Type Report Highlights
| Aspects | Details |
Market Size By 2033 | USD 537.8 Million |
Growth Rate | CAGR of 4.1% |
Forecast period | 2024 – 2033 |
Report Pages | 280 |
By Type |
|
By Application |
|
By Distribution Channel |
|
By Region |
|
Key Market Players | F. Hoffmann-La Roche Ltd, Ypsomed AG, Unilife Corporation, Owen Mumford Ltd, ARKRAY Inc, Terumo Corporation, Novo Nordisk A/S, Integra Lifesciences Corporation., LifeScan, Medtronic Plc |
Key Market Segments
By Type
- Standard Lancet
- Safety Lancet
- Others
By Application
- Glucose Testing
- Cholesterol Testing
- Others
By Distribution Channel
- Online Channel
- Offline Channel
By Region
- North America
○ U.S.
○ Canada
○ Mexico
- Europe
○ France
○ Germany
○ Italy
○ Spain
○ UK
○ Rest of Europe
- Asia-Pacific
○ China
○ Japan
○ India
○ South Korea
○ Australia
○ Rest of Asia-Pacific
- LAMEA
○ Brazil
○ South Africa
○ Saudi Arabia
○ Rest of LAMEA
- Key Market Players
○ Medtronic Plc
○ Integra Lifesciences Corporation.
○ Unilife Corporation
○ LifeScan
○ Novo Nordisk A/S
○ Owen Mumford Ltd
○ Ypsomed AG
○ F. Hoffmann-La Roche Ltd
○ Terumo Corporation
○ ARKRAY Inc
Table of Content
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter’s Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: HOME USE LANCING DEVICES MARKET, BY TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Type
4.2. Standard Lancet
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Safety Lancet
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Others
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: HOME USE LANCING DEVICES MARKET, BY APPLICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. Glucose Testing
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Cholesterol Testing
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Others
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL
6.1. Market Overview
6.1.1 Market Size and Forecast, By Distribution Channel
6.2. Online Channel
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Offline Channel
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
CHAPTER 7: HOME USE LANCING DEVICES MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Type
7.2.3. Market Size and Forecast, By Application
7.2.4. Market Size and Forecast, By Distribution Channel
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Home Use Lancing Devices Market
7.2.6.1. Market Size and Forecast, By Type
7.2.6.2. Market Size and Forecast, By Application
7.2.6.3. Market Size and Forecast, By Distribution Channel
7.2.7. Canada Home Use Lancing Devices Market
7.2.7.1. Market Size and Forecast, By Type
7.2.7.2. Market Size and Forecast, By Application
7.2.7.3. Market Size and Forecast, By Distribution Channel
7.2.8. Mexico Home Use Lancing Devices Market
7.2.8.1. Market Size and Forecast, By Type
7.2.8.2. Market Size and Forecast, By Application
7.2.8.3. Market Size and Forecast, By Distribution Channel
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Type
7.3.3. Market Size and Forecast, By Application
7.3.4. Market Size and Forecast, By Distribution Channel
7.3.5. Market Size and Forecast, By Country
7.3.6. France Home Use Lancing Devices Market
7.3.6.1. Market Size and Forecast, By Type
7.3.6.2. Market Size and Forecast, By Application
7.3.6.3. Market Size and Forecast, By Distribution Channel
7.3.7. Germany Home Use Lancing Devices Market
7.3.7.1. Market Size and Forecast, By Type
7.3.7.2. Market Size and Forecast, By Application
7.3.7.3. Market Size and Forecast, By Distribution Channel
7.3.8. Italy Home Use Lancing Devices Market
7.3.8.1. Market Size and Forecast, By Type
7.3.8.2. Market Size and Forecast, By Application
7.3.8.3. Market Size and Forecast, By Distribution Channel
7.3.9. Spain Home Use Lancing Devices Market
7.3.9.1. Market Size and Forecast, By Type
7.3.9.2. Market Size and Forecast, By Application
7.3.9.3. Market Size and Forecast, By Distribution Channel
7.3.10. UK Home Use Lancing Devices Market
7.3.10.1. Market Size and Forecast, By Type
7.3.10.2. Market Size and Forecast, By Application
7.3.10.3. Market Size and Forecast, By Distribution Channel
7.3.11. Rest Of Europe Home Use Lancing Devices Market
7.3.11.1. Market Size and Forecast, By Type
7.3.11.2. Market Size and Forecast, By Application
7.3.11.3. Market Size and Forecast, By Distribution Channel
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Type
7.4.3. Market Size and Forecast, By Application
7.4.4. Market Size and Forecast, By Distribution Channel
7.4.5. Market Size and Forecast, By Country
7.4.6. China Home Use Lancing Devices Market
7.4.6.1. Market Size and Forecast, By Type
7.4.6.2. Market Size and Forecast, By Application
7.4.6.3. Market Size and Forecast, By Distribution Channel
7.4.7. Japan Home Use Lancing Devices Market
7.4.7.1. Market Size and Forecast, By Type
7.4.7.2. Market Size and Forecast, By Application
7.4.7.3. Market Size and Forecast, By Distribution Channel
7.4.8. India Home Use Lancing Devices Market
7.4.8.1. Market Size and Forecast, By Type
7.4.8.2. Market Size and Forecast, By Application
7.4.8.3. Market Size and Forecast, By Distribution Channel
7.4.9. South Korea Home Use Lancing Devices Market
7.4.9.1. Market Size and Forecast, By Type
7.4.9.2. Market Size and Forecast, By Application
7.4.9.3. Market Size and Forecast, By Distribution Channel
7.4.10. Australia Home Use Lancing Devices Market
7.4.10.1. Market Size and Forecast, By Type
7.4.10.2. Market Size and Forecast, By Application
7.4.10.3. Market Size and Forecast, By Distribution Channel
7.4.11. Rest of Asia-Pacific Home Use Lancing Devices Market
7.4.11.1. Market Size and Forecast, By Type
7.4.11.2. Market Size and Forecast, By Application
7.4.11.3. Market Size and Forecast, By Distribution Channel
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Type
7.5.3. Market Size and Forecast, By Application
7.5.4. Market Size and Forecast, By Distribution Channel
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Home Use Lancing Devices Market
7.5.6.1. Market Size and Forecast, By Type
7.5.6.2. Market Size and Forecast, By Application
7.5.6.3. Market Size and Forecast, By Distribution Channel
7.5.7. South Africa Home Use Lancing Devices Market
7.5.7.1. Market Size and Forecast, By Type
7.5.7.2. Market Size and Forecast, By Application
7.5.7.3. Market Size and Forecast, By Distribution Channel
7.5.8. Saudi Arabia Home Use Lancing Devices Market
7.5.8.1. Market Size and Forecast, By Type
7.5.8.2. Market Size and Forecast, By Application
7.5.8.3. Market Size and Forecast, By Distribution Channel
7.5.9. Rest of LAMEA Home Use Lancing Devices Market
7.5.9.1. Market Size and Forecast, By Type
7.5.9.2. Market Size and Forecast, By Application
7.5.9.3. Market Size and Forecast, By Distribution Channel
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Medtronic Plc
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Integra Lifesciences Corporation.
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Unilife Corporation
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. LifeScan
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Novo Nordisk A/S
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Owen Mumford Ltd
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Ypsomed AG
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. F. Hoffmann-La Roche Ltd
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Terumo Corporation
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. ARKRAY Inc
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. GLOBAL HOME USE LANCING DEVICES MARKET, BY TYPE, 2024 – 2033 ($MILLION)
TABLE 2. HOME USE LANCING DEVICES MARKET FOR STANDARD LANCET, BY REGION, 2024 – 2033 ($MILLION)
TABLE 3. HOME USE LANCING DEVICES MARKET FOR SAFETY LANCET, BY REGION, 2024 – 2033 ($MILLION)
TABLE 4. HOME USE LANCING DEVICES MARKET FOR OTHERS, BY REGION, 2024 – 2033 ($MILLION)
TABLE 5. GLOBAL HOME USE LANCING DEVICES MARKET, BY APPLICATION, 2024 – 2033 ($MILLION)
TABLE 6. HOME USE LANCING DEVICES MARKET FOR GLUCOSE TESTING, BY REGION, 2024 – 2033 ($MILLION)
TABLE 7. HOME USE LANCING DEVICES MARKET FOR CHOLESTEROL TESTING, BY REGION, 2024 – 2033 ($MILLION)
TABLE 8. HOME USE LANCING DEVICES MARKET FOR OTHERS, BY REGION, 2024 – 2033 ($MILLION)
TABLE 9. GLOBAL HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 – 2033 ($MILLION)
TABLE 10. HOME USE LANCING DEVICES MARKET FOR ONLINE CHANNEL, BY REGION, 2024 – 2033 ($MILLION)
TABLE 11. HOME USE LANCING DEVICES MARKET FOR OFFLINE CHANNEL, BY REGION, 2024 – 2033 ($MILLION)
TABLE 12. HOME USE LANCING DEVICES MARKET, BY REGION, 2024 – 2033 ($MILLION)
TABLE 13. NORTH AMERICA HOME USE LANCING DEVICES MARKET, BY COUNTRY, 2024 – 2033 ($MILLION)
TABLE 14. NORTH AMERICA HOME USE LANCING DEVICES MARKET, BY TYPE, 2024 – 2033 ($MILLION)
TABLE 15. NORTH AMERICA HOME USE LANCING DEVICES MARKET, BY APPLICATION, 2024 – 2033 ($MILLION)
TABLE 16. NORTH AMERICA HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 – 2033 ($MILLION)
TABLE 17. U.S. HOME USE LANCING DEVICES MARKET, BY TYPE, 2024 – 2033 ($MILLION)
TABLE 18. U.S. HOME USE LANCING DEVICES MARKET, BY APPLICATION, 2024 – 2033 ($MILLION)
TABLE 19. U.S. HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 – 2033 ($MILLION)
TABLE 20. CANADA HOME USE LANCING DEVICES MARKET, BY TYPE, 2024 – 2033 ($MILLION)
TABLE 21. CANADA HOME USE LANCING DEVICES MARKET, BY APPLICATION, 2024 – 2033 ($MILLION)
TABLE 22. CANADA HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 – 2033 ($MILLION)
TABLE 23. MEXICO HOME USE LANCING DEVICES MARKET, BY TYPE, 2024 – 2033 ($MILLION)
TABLE 24. MEXICO HOME USE LANCING DEVICES MARKET, BY APPLICATION, 2024 – 2033 ($MILLION)
TABLE 25. MEXICO HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 – 2033 ($MILLION)
TABLE 26. EUROPE HOME USE LANCING DEVICES MARKET, BY COUNTRY, 2024 – 2033 ($MILLION)
TABLE 27. EUROPE HOME USE LANCING DEVICES MARKET, BY TYPE, 2024 – 2033 ($MILLION)
TABLE 28. EUROPE HOME USE LANCING DEVICES MARKET, BY APPLICATION, 2024 – 2033 ($MILLION)
TABLE 29. EUROPE HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 – 2033 ($MILLION)
TABLE 30. FRANCE HOME USE LANCING DEVICES MARKET, BY TYPE, 2024 – 2033 ($MILLION)
TABLE 31. FRANCE HOME USE LANCING DEVICES MARKET, BY APPLICATION, 2024 – 2033 ($MILLION)
TABLE 32. FRANCE HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 – 2033 ($MILLION)
TABLE 33. GERMANY HOME USE LANCING DEVICES MARKET, BY TYPE, 2024 – 2033 ($MILLION)
TABLE 34. GERMANY HOME USE LANCING DEVICES MARKET, BY APPLICATION, 2024 – 2033 ($MILLION)
TABLE 35. GERMANY HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 – 2033 ($MILLION)
TABLE 36. ITALY HOME USE LANCING DEVICES MARKET, BY TYPE, 2024 – 2033 ($MILLION)
TABLE 37. ITALY HOME USE LANCING DEVICES MARKET, BY APPLICATION, 2024 – 2033 ($MILLION)
TABLE 38. ITALY HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 – 2033 ($MILLION)
TABLE 39. SPAIN HOME USE LANCING DEVICES MARKET, BY TYPE, 2024 – 2033 ($MILLION)
TABLE 40. SPAIN HOME USE LANCING DEVICES MARKET, BY APPLICATION, 2024 – 2033 ($MILLION)
TABLE 41. SPAIN HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 – 2033 ($MILLION)
TABLE 42. UK HOME USE LANCING DEVICES MARKET, BY TYPE, 2024 – 2033 ($MILLION)
TABLE 43. UK HOME USE LANCING DEVICES MARKET, BY APPLICATION, 2024 – 2033 ($MILLION)
TABLE 44. UK HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 – 2033 ($MILLION)
TABLE 45. REST OF EUROPE HOME USE LANCING DEVICES MARKET, BY TYPE, 2024 – 2033 ($MILLION)
TABLE 46. REST OF EUROPE HOME USE LANCING DEVICES MARKET, BY APPLICATION, 2024 – 2033 ($MILLION)
TABLE 47. REST OF EUROPE HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 – 2033 ($MILLION)
TABLE 48. ASIA-PACIFIC HOME USE LANCING DEVICES MARKET, BY COUNTRY, 2024 – 2033 ($MILLION)
TABLE 49. ASIA-PACIFIC HOME USE LANCING DEVICES MARKET, BY TYPE, 2024 – 2033 ($MILLION)
TABLE 50. ASIA-PACIFIC HOME USE LANCING DEVICES MARKET, BY APPLICATION, 2024 – 2033 ($MILLION)
TABLE 51. ASIA-PACIFIC HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 – 2033 ($MILLION)
TABLE 52. CHINA HOME USE LANCING DEVICES MARKET, BY TYPE, 2024 – 2033 ($MILLION)
TABLE 53. CHINA HOME USE LANCING DEVICES MARKET, BY APPLICATION, 2024 – 2033 ($MILLION)
TABLE 54. CHINA HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 – 2033 ($MILLION)
TABLE 55. JAPAN HOME USE LANCING DEVICES MARKET, BY TYPE, 2024 – 2033 ($MILLION)
TABLE 56. JAPAN HOME USE LANCING DEVICES MARKET, BY APPLICATION, 2024 – 2033 ($MILLION)
TABLE 57. JAPAN HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 – 2033 ($MILLION)
TABLE 58. INDIA HOME USE LANCING DEVICES MARKET, BY TYPE, 2024 – 2033 ($MILLION)
TABLE 59. INDIA HOME USE LANCING DEVICES MARKET, BY APPLICATION, 2024 – 2033 ($MILLION)
TABLE 60. INDIA HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 – 2033 ($MILLION)
TABLE 61. SOUTH KOREA HOME USE LANCING DEVICES MARKET, BY TYPE, 2024 – 2033 ($MILLION)
TABLE 62. SOUTH KOREA HOME USE LANCING DEVICES MARKET, BY APPLICATION, 2024 – 2033 ($MILLION)
TABLE 63. SOUTH KOREA HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 – 2033 ($MILLION)
TABLE 64. AUSTRALIA HOME USE LANCING DEVICES MARKET, BY TYPE, 2024 – 2033 ($MILLION)
TABLE 65. AUSTRALIA HOME USE LANCING DEVICES MARKET, BY APPLICATION, 2024 – 2033 ($MILLION)
TABLE 66. AUSTRALIA HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 – 2033 ($MILLION)
TABLE 67. REST OF ASIA-PACIFIC HOME USE LANCING DEVICES MARKET, BY TYPE, 2024 – 2033 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC HOME USE LANCING DEVICES MARKET, BY APPLICATION, 2024 – 2033 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 – 2033 ($MILLION)
TABLE 70. LAMEA HOME USE LANCING DEVICES MARKET, BY COUNTRY, 2024 – 2033 ($MILLION)
TABLE 71. LAMEA HOME USE LANCING DEVICES MARKET, BY TYPE, 2024 – 2033 ($MILLION)
TABLE 72. LAMEA HOME USE LANCING DEVICES MARKET, BY APPLICATION, 2024 – 2033 ($MILLION)
TABLE 73. LAMEA HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 – 2033 ($MILLION)
TABLE 74. BRAZIL HOME USE LANCING DEVICES MARKET, BY TYPE, 2024 – 2033 ($MILLION)
TABLE 75. BRAZIL HOME USE LANCING DEVICES MARKET, BY APPLICATION, 2024 – 2033 ($MILLION)
TABLE 76. BRAZIL HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 – 2033 ($MILLION)
TABLE 77. SOUTH AFRICA HOME USE LANCING DEVICES MARKET, BY TYPE, 2024 – 2033 ($MILLION)
TABLE 78. SOUTH AFRICA HOME USE LANCING DEVICES MARKET, BY APPLICATION, 2024 – 2033 ($MILLION)
TABLE 79. SOUTH AFRICA HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 – 2033 ($MILLION)
TABLE 80. SAUDI ARABIA HOME USE LANCING DEVICES MARKET, BY TYPE, 2024 – 2033 ($MILLION)
TABLE 81. SAUDI ARABIA HOME USE LANCING DEVICES MARKET, BY APPLICATION, 2024 – 2033 ($MILLION)
TABLE 82. SAUDI ARABIA HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 – 2033 ($MILLION)
TABLE 83. REST OF LAMEA HOME USE LANCING DEVICES MARKET, BY TYPE, 2024 – 2033 ($MILLION)
TABLE 84. REST OF LAMEA HOME USE LANCING DEVICES MARKET, BY APPLICATION, 2024 – 2033 ($MILLION)
TABLE 85. REST OF LAMEA HOME USE LANCING DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2024 – 2033 ($MILLION)
TABLE 86. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 87. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 88. MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 89. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 90. MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 91. INTEGRA LIFESCIENCES CORPORATION.: KEY EXECUTIVES
TABLE 92. INTEGRA LIFESCIENCES CORPORATION.: COMPANY SNAPSHOT
TABLE 93. INTEGRA LIFESCIENCES CORPORATION.: OPERATING SEGMENTS
TABLE 94. INTEGRA LIFESCIENCES CORPORATION.: PRODUCT PORTFOLIO
TABLE 95. INTEGRA LIFESCIENCES CORPORATION.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 96. UNILIFE CORPORATION: KEY EXECUTIVES
TABLE 97. UNILIFE CORPORATION: COMPANY SNAPSHOT
TABLE 98. UNILIFE CORPORATION: OPERATING SEGMENTS
TABLE 99. UNILIFE CORPORATION: PRODUCT PORTFOLIO
TABLE 100. UNILIFE CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 101. LIFESCAN: KEY EXECUTIVES
TABLE 102. LIFESCAN: COMPANY SNAPSHOT
TABLE 103. LIFESCAN: OPERATING SEGMENTS
TABLE 104. LIFESCAN: PRODUCT PORTFOLIO
TABLE 105. LIFESCAN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 106. NOVO NORDISK A/S: KEY EXECUTIVES
TABLE 107. NOVO NORDISK A/S: COMPANY SNAPSHOT
TABLE 108. NOVO NORDISK A/S: OPERATING SEGMENTS
TABLE 109. NOVO NORDISK A/S: PRODUCT PORTFOLIO
TABLE 110. NOVO NORDISK A/S: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 111. OWEN MUMFORD LTD: KEY EXECUTIVES
TABLE 112. OWEN MUMFORD LTD: COMPANY SNAPSHOT
TABLE 113. OWEN MUMFORD LTD: OPERATING SEGMENTS
TABLE 114. OWEN MUMFORD LTD: PRODUCT PORTFOLIO
TABLE 115. OWEN MUMFORD LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 116. YPSOMED AG: KEY EXECUTIVES
TABLE 117. YPSOMED AG: COMPANY SNAPSHOT
TABLE 118. YPSOMED AG: OPERATING SEGMENTS
TABLE 119. YPSOMED AG: PRODUCT PORTFOLIO
TABLE 120. YPSOMED AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 121. F. HOFFMANN-LA ROCHE LTD: KEY EXECUTIVES
TABLE 122. F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT
TABLE 123. F. HOFFMANN-LA ROCHE LTD: OPERATING SEGMENTS
TABLE 124. F. HOFFMANN-LA ROCHE LTD: PRODUCT PORTFOLIO
TABLE 125. F. HOFFMANN-LA ROCHE LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 126. TERUMO CORPORATION: KEY EXECUTIVES
TABLE 127. TERUMO CORPORATION: COMPANY SNAPSHOT
TABLE 128. TERUMO CORPORATION: OPERATING SEGMENTS
TABLE 129. TERUMO CORPORATION: PRODUCT PORTFOLIO
TABLE 130. TERUMO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 131. ARKRAY INC: KEY EXECUTIVES
TABLE 132. ARKRAY INC: COMPANY SNAPSHOT
TABLE 133. ARKRAY INC: OPERATING SEGMENTS
TABLE 134. ARKRAY INC: PRODUCT PORTFOLIO
TABLE 135. ARKRAY INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL HOME USE LANCING DEVICES MARKET, 2024 – 2033
FIGURE 2. SEGMENTATION OF HOME USE LANCING DEVICES MARKET, 2024 – 2033
FIGURE 3. TOP INVESTMENT POCKET IN HOME USE LANCING DEVICES MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALHOME USE LANCING DEVICES MARKET
FIGURE 10. GLOBAL HOME USE LANCING DEVICES MARKET SEGMENTATION, BY TYPE
FIGURE 11. HOME USE LANCING DEVICES MARKET FOR STANDARD LANCET, BY COUNTRY, 2024 – 2033 ($MILLION)
FIGURE 12. HOME USE LANCING DEVICES MARKET FOR SAFETY LANCET, BY COUNTRY, 2024 – 2033 ($MILLION)
FIGURE 13. HOME USE LANCING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2024 – 2033 ($MILLION)
FIGURE 14. GLOBAL HOME USE LANCING DEVICES MARKET SEGMENTATION, BY APPLICATION
FIGURE 15. HOME USE LANCING DEVICES MARKET FOR GLUCOSE TESTING, BY COUNTRY, 2024 – 2033 ($MILLION)
FIGURE 16. HOME USE LANCING DEVICES MARKET FOR CHOLESTEROL TESTING, BY COUNTRY, 2024 – 2033 ($MILLION)
FIGURE 17. HOME USE LANCING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2024 – 2033 ($MILLION)
FIGURE 18. GLOBAL HOME USE LANCING DEVICES MARKET SEGMENTATION, BY DISTRIBUTION CHANNEL
FIGURE 19. HOME USE LANCING DEVICES MARKET FOR ONLINE CHANNEL, BY COUNTRY, 2024 – 2033 ($MILLION)
FIGURE 20. HOME USE LANCING DEVICES MARKET FOR OFFLINE CHANNEL, BY COUNTRY, 2024 – 2033 ($MILLION)
FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 25. COMPETITIVE DASHBOARD
FIGURE 26. COMPETITIVE HEATMAP: HOME USE LANCING DEVICES MARKET
FIGURE 27. TOP PLAYER POSITIONING, 2023
FIGURE 28. MEDTRONIC PLC: NET SALES, 2021-2023 ($MILLION)
FIGURE 29. MEDTRONIC PLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 30. MEDTRONIC PLC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 31. INTEGRA LIFESCIENCES CORPORATION.: NET SALES, 2021-2023 ($MILLION)
FIGURE 32. INTEGRA LIFESCIENCES CORPORATION.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 33. INTEGRA LIFESCIENCES CORPORATION.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 34. UNILIFE CORPORATION: NET SALES, 2021-2023 ($MILLION)
FIGURE 35. UNILIFE CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 36. UNILIFE CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 37. LIFESCAN: NET SALES, 2021-2023 ($MILLION)
FIGURE 38. LIFESCAN: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 39. LIFESCAN: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 40. NOVO NORDISK A/S: NET SALES, 2021-2023 ($MILLION)
FIGURE 41. NOVO NORDISK A/S: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 42. NOVO NORDISK A/S: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 43. OWEN MUMFORD LTD: NET SALES, 2021-2023 ($MILLION)
FIGURE 44. OWEN MUMFORD LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 45. OWEN MUMFORD LTD: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 46. YPSOMED AG: NET SALES, 2021-2023 ($MILLION)
FIGURE 47. YPSOMED AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 48. YPSOMED AG: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 49. F. HOFFMANN-LA ROCHE LTD: NET SALES, 2021-2023 ($MILLION)
FIGURE 50. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 51. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 52. TERUMO CORPORATION: NET SALES, 2021-2023 ($MILLION)
FIGURE 53. TERUMO CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 54. TERUMO CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 55. ARKRAY INC: NET SALES, 2021-2023 ($MILLION)
FIGURE 56. ARKRAY INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 57. ARKRAY INC: REVENUE SHARE, BY REGION, 2023 (%)
Allied Market Research（アライドマーケットリサーチ）は広範な調査範囲と独自の360度メソドロジーで高リピート率を誇る（※）インドの調査会社です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
※Allied Market Researchでは2024年5月より価格体系を変更しました。弊社ウェブサイトでは旧価格体系で表示されているレポートについても新価格体系でのお取り扱いとなります。予めご了承ください。
| シングルユーザライセンス （Business 1 User License） | エンタープライズライセンス | クラウドアクセス |
| USD 4,065 | USD 6,809 | USD 2,439 |
その他の価格体系についてはお問い合わせください。
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス（Business 1 User License）
- ご提供ファイル：PDF
- 印刷はユーザー数のみ可能です。例：シングルユーザライセンスに1名ユーザー追加いただいた場合には印刷は2回のみ可。
- 2名以上でご利用の場合にはユーザー数×USD200の加算で最大4名までユーザーの追加が可能です。
- エンタープライズライセンス
- ご提供ファイル：印刷可能PDF＋Excel
- クラウドアクセス
- 納品後45日間のみオンラインでのご閲覧のみのライセンスです。
- ダウンロード、印刷、内容のコピー＆ペーストは非対応です。
- シングルユーザライセンス（Business 1 User License）
- 納品方法
- Eメール
- 納期
- レポートタイトルにより異なります。詳細はお気軽にお問い合わせください。
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはAllied Market Researchの日本の販売代理店として、Allied Market Researchのレポートを取り扱っております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にSEMABIZまでご連絡ください。
※参照：Allied Market Research 公式ウェブサイト